摘要
目的探讨Bakri球囊放置术联合缩宫素穴位注射治疗产后出血(PPH)的临床效果,为临床应用提供参考依据。方法 54例产后出血产妇,随机分为对照组和研究组,每组27例。对照组患者单纯予以缩宫素穴位注射止血,研究组产妇在对照组基础上加用Bakri球囊压迫止血。比较两组产妇不同时间点出血量,并记录两组治疗结局。结果两组术中出血量比较差异无统计学意义(P>0.05);产后2 h、24 h,研究组产妇出血量分别为(235.27±35.44)、(595.19±90.35)ml,均显著低于对照组的(267.19±40.25)、(669.17±130.26)ml,差异具有统计学意义(t=3.093、3.638, P<0.05)。研究组产妇止血成功22例(81.48%),明显多于对照组的14例(51.85%),差异具有统计学意义(χ2=5.333, P<0.05)。结论 Bakri球囊放置术联合缩宫素穴位注射可有效改善产后出血产妇临床表现,提升预后质量,值得临床推广应用。
Objective To discuss the clinical effect of Bakri balloon placement combined with oxytocin acupoint injection in the treatment of postpartum hemorrhage(PPH), so as to provide reference for clinical application. Methods A total of 54 maternal women with postpartum hemorrhage were randomly divided into control group and research group, with 27 cases in each group. The control group received oxytocin acupoint injection for hemostasis, and the research group received Bakri balloon compression for hemostasis on the basis of the control group. The bleeding volume at different time points was compared between the two groups, and the treatment outcomes of the two groups were recorded. Results Both groups had no statistically significant in intraoperative bleeding volume(P>0.05). At postpartum 2 and 24 h, the research group had significantly lower bleeding volume respectively as(235.27±35.44) and(595.19±90.35) ml than(267.19±40.25) and(669.17±130.26) ml in the control group. Their difference was statistically significant(t=3.093, 3.638, P<0.05). The research group had obviously more successful hemostasis cases as 22 cases(81.48%) than 14 cases(51.85%) in the control group, and the difference was statistically significant(χ2=5.333, P<0.05). Conclusion Combination of Bakri balloon placement and oxytocin acupoint injection can effectively improve the clinical manifestations of postpartum hemorrhage and improve the quality of prognosis. It is worthy of clinical promotion and application.
作者
谢翠翠
郭芳
李娟
聂东娥
XIE Cui-cui;GUO Fang;LI Juan(Department of Obstetrics, Heyuan Maternal and Child Health Hospital, Heyuan 517000, China)
出处
《中国现代药物应用》
2019年第6期18-19,共2页
Chinese Journal of Modern Drug Application
基金
河源市社会发展科技计划项目(项目编号:180706100222519)